Standard PAH therapy improves long term survival in CTEPH patients-Reference-Cited by-同舟云学术

Standard PAH therapy improves long term survival in CTEPH patients

Published:2010-04-25 Issue:9 Volume:99 Page:553-556
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Seyfarth Hans-Juergen,Halank Michael,Wilkens Heinrike,Schäfers Hans-Joachim,Ewert Ralf,Riedel Martin,Schuster Ernst,Pankau Hans,Hammerschmidt Stefan,Wirtz Hubert

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-010-0156-4.pdf

Reference26 articles.

1. Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schonauer V, Exner M, Klepetko W, Kneussl MP, Maurer G, Lang I (2005) Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 93:512–516

2. Bonderman D, Nowotny R, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Klepetko W, Lang IM (2005) Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 128:2599–2603

3. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ (2004) Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 23:595–600

4. Bresser P, Pepke-Zaba J, Jais X, Humbert M, Hoeper MM (2006) Medical therapies for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3:594–600

5. Dartevelle P, Fadel E, Mussot S, Chapelier A, Hervé P, de Perrot M, Cerrina J, Ladurie FL, Lehouerou D, Humbert M, Sitbon O, Simonneau G (2004) Chronic thromboembolic pulmonary hypertension. Eur Respir J 23:637–648

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of off‐label targeted drugs on long‐term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry;Respirology;2024-03-17

2. Akute und chronische Lungenembolie;Kompendium der modernen Herzchirurgie beim Erwachsenen;2020

3. Riociguat in PAH and CTEPH: Strategies for Patient Management;Pulmonary Therapy;2017-02-20

4. sGC stimulators: Evidence for riociguat beyond groups 1 and 4 pulmonary hypertension;Respiratory Medicine;2017-01

5. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension;Annals of the American Thoracic Society;2016-07